ORACLE INVESTMENT MANAGEMENT INC - Q2 2020 holdings

$788 Million is the total value of ORACLE INVESTMENT MANAGEMENT INC's 19 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 25.0% .

 Value Shares↓ Weighting
AXDX SellACCELERATE DIAGNOSTICS INC$61,685,000
+80.5%
4,068,942
-0.8%
7.83%
-22.9%
SLNO SellSOLENO THERAPEUTICS INC$8,148,000
-11.6%
3,670,384
-5.2%
1.03%
-62.2%
BHVN SellBIOHAVEN PHARMACTL HLDG CO Lcall$2,494,000
+1044.0%
63,100
-36.9%
0.32%
+386.2%
BIOL SellBIOLASE INC$1,000,000
-48.5%
1,739,100
-66.4%
0.13%
-78.0%
BIIB SellBIOGEN INC$987,000
-35.9%
3,688
-24.2%
0.12%
-72.7%
AXDX SellACCELERATE DIAGNOSTICS INCcall$686,000
+1147.3%
137,900
-64.5%
0.09%
+443.8%
AMRN ExitAMARIN CORP PLCcall$0-351,000
-100.0%
-0.00%
VRML ExitVERMILLION INC$0-9,825,289
-100.0%
-2.43%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
OPKO HEALTH INC42Q3 202310.6%
PACIFIC BIOSCIENCES CALIF IN42Q3 202322.6%
BIOGEN INC42Q3 20230.6%
QUIDEL CORP36Q1 202252.5%
AMARIN CORP PLC31Q3 202123.1%
VERMILLION INC28Q1 20203.8%
AGENUS INC25Q3 20239.8%
TESARO INC23Q4 201827.8%
ACCELERATE DIAGNOSTICS INC23Q2 202323.0%
MAZOR ROBOTICS LTD20Q1 201818.0%

View ORACLE INVESTMENT MANAGEMENT INC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-15
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14

View ORACLE INVESTMENT MANAGEMENT INC's complete filings history.

Compare quarters

Export ORACLE INVESTMENT MANAGEMENT INC's holdings